secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aardvark Therapeutics, Inc. (AARD)
CIK:        0001774857
Form:       8-K
Filed at:   2026-03-24T23:59:59+00:00
Accession:  0001193125-26-120164
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aardvark enters $150M equity distribution agreement with Piper Sandler
----------------------------------------------------------------------

- May sell up to $150M of common stock at market through Piper Sandler as agent.
- Commission of 3.0% of gross sales price per share sold under agreement.
- Company has no obligation to sell any shares; sales at Company's discretion.
- Agreement filed as Exhibit 10.1; shelf registration on Form S-3 filed same day.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526120164/0001193125-26-120164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1774857/000119312526120164/ck0001774857-20260323.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-120164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer